Combining micro-computed tomography (CT) with a photographic approach could improve accuracy and specificity when digitizing natural objects, Japanese researchers have found.

Critical access hospitals, ambulatory care and office-based surgical practices would be subject to new requirements for pain assessment and management under proposals released by the Joint Commission, with safe prescribing of opioids needing to be an “organizational priority” in all three settings.

The American Society of Radiologic Technologists (ASRT) has announced the winners of its 2018 ASRT Award for Advocacy: The Pennsylvania Society of Radiologic Technologists and Brian Rich, board chair of the Texas Society of Radiologic Technologists.

One of the first outpatient MRI providers in the United States was originally a McDonald’s owned by the company’s famous CEO, Ray Kroc. That’s one of several bits of trivia included in a new article from Forbes focused on the history of MRIs.

Automated breast ultrasound (ABUS) offers improved breast cancer screening for patients with dense breast tissue and could provide specialists with a significant improvement over handheld screening ultrasound. However, some clinicians worry it may take radiologists too long to interpret ABUS exams, making it less than ideal for population-based screening.

HHS Secretary Alex Azar was admitted to a hospital due to a ‘minor infection,’ the agency told reporters in a Sunday night press release. The statement only said Azar received intravenous antibiotics and “has been admitted to a hospital for observation.” It didn’t address where he was hospitalized or how long he had shown symptoms.

At first, the 2013 Boston Marathon was going more smoothly for hospitals in and around downtown Boston compared to the prior year’s event, when a heat wave meant more runners needed medical attention. David Reisman, MHA, senior administrative director of emergency medicine at Massachusetts General Hospital, admitted he had begun to think it would be an easy day.

A noninvasive imaging biomarker known as 18F fluorocholine PET/CT has been proving its capability in detecting certain cancers for years, but fresh research out of Honolulu suggests it could be especially useful in identifying chronic liver disease.